Trial Profile
Biomarkers in Obese Patients With Knee Osteoarthritis Following Long-term Weight Maintenance
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Biomarker; Therapeutic Use
- Acronyms BIO-LOSEIT-II
- 21 Mar 2019 Status changed from active, no longer recruiting to completed.
- 25 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 11 Nov 2016 Status changed from not yet recruiting to recruiting.